SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

Whats the point?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Rubyred77 Member Profile
 
Followed By 7
Posts 381
Boards Moderated 1
Alias Born 07/27/15
160x600 placeholder
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 3/17/2017 6:06:45 AM
Anavex Life Sciences to Present at Oppenheimer 27th Annual Healthcare Conference "GlobeNewswire Inc." - 3/15/2017 7:00:00 AM
Anavex Life Sciences to Present at 14th Annual BIO Asia International Conference "GlobeNewswire Inc." - 3/13/2017 7:00:00 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 3/10/2017 7:17:05 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 2/27/2017 4:37:05 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 2/16/2017 1:53:29 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 2/13/2017 5:00:22 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/13/2017 9:04:04 AM
Anavex Life Sciences Strengthens Board of Directors "GlobeNewswire Inc." - 2/13/2017 7:00:00 AM
Anavex Life Sciences’ CEO Joins BIO CEO & Investor Conference 2017 Panel “Designing Clinical Trials in 21st Century Cures... "GlobeNewswire Inc." - 2/9/2017 7:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 2/7/2017 4:33:56 PM
Noble Capital Markets Initiates Research Coverage on Anavex Life Sciences Corp. (AVXL) "PR Newswire (US)" - 2/7/2017 8:00:00 AM
Anavex Reports Fiscal First Quarter 2017 Financial Results "GlobeNewswire Inc." - 2/7/2017 7:00:00 AM
Anavex Life Sciences to Present at Noble Capital Markets’ Thirteenth Annual Investor Conference "GlobeNewswire Inc." - 1/23/2017 8:00:00 AM
Anavex Life Sciences Receives Grant From Rettsyndrome.org to Commence U.S. Phase 2 Trial in 2017 "GlobeNewswire Inc." - 1/19/2017 7:00:00 AM
Anavex Life Sciences Obtains Permanent Dismissal of All Claims in Securities Lawsuit "GlobeNewswire Inc." - 1/3/2017 7:00:00 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 12/14/2016 4:09:24 PM
Traders News Issues New Reports and Features a New OTCQB Company Profile "InvestorsHub NewsWire" - 12/13/2016 9:25:00 AM
Anavex Life Sciences Reports Fiscal 2016 Financial Results - Conference Call and Webcast Today at 4:30 p.m. ET to Discuss Fin... "GlobeNewswire Inc." - 12/12/2016 7:00:00 AM
Anavex Life Sciences Announces 12-Month Data of ANAVEX 2-73 in a Phase 2a Study in Mild-to-Moderate Alzheimer’s Disease Pat... "GlobeNewswire Inc." - 12/8/2016 7:00:00 AM
Anavex Life Sciences to Present at Annual Mental Health Parity Addiction Equity Act Roundtable at U.S. Capitol, Washington, D... "GlobeNewswire Inc." - 12/1/2016 7:00:00 AM
Anavex Life Sciences Appoints Three Distinguished Researchers To Scientific Advisory Board "GlobeNewswire Inc." - 11/28/2016 7:00:00 AM
Anavex Life Sciences Announces Data on 41-Week Treatment of ANAVEX 2-73 for Patients with Alzheimer’s Disease − Investiga... "GlobeNewswire Inc." - 11/22/2016 7:00:00 AM
Anavex Life Sciences Novel Sigma-1 / Sigma-2 Ligand Shows Encouraging Results as an Analgesic in Animal Models of Neuropathic... "GlobeNewswire Inc." - 11/14/2016 7:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/21/2016 12:49:36 PM
Rubyred77   Monday, 03/20/17 09:42:38 PM
Re: Whatsupp post# 96626
Post # of 97390 
Whats the point?
People don't survive Alzheimer's disease. So imagine how much people pass away before even reaching 85 to meet that statistic.

Taken from the same Alzheimer Association is this:

• Every 66 seconds, someone in the United States
develops Alzheimer’s.
• By mid-century, someone in the United States will
develop the disease every 33 seconds.


https://www.alz.org/documents_custom/2016-facts-and-figures.pdf

page #22


SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist